Clinical trial
Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis
NCT06413459 is registered in ClinicalTrials.gov with Ospedale San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis
- Lead sponsor
- Ospedale San Raffaele
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 8, 2021
- Completion date
- March 30, 2027
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cystic fibrosis lung, non-tuberculous mycobacterial pneumonia